|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
27.11.25 - 04:24
|
Mesoblast shares: bull vs. bear (Fool)
|
|
|
Two experts have presented their case for buying and selling the ASX biotech stock.
The post Mesoblast shares: bull vs. bear appeared first on The Motley Fool Australia....
|
|
|
|
|
|
|
|
|
27.11.25 - 00:36
|
Elanco executive appointed as Neurizon′s Board Observer (PR Newswire)
|
|
|
MELBOURNE, Australia, Nov. 26, 2025 /PRNewswire/ -- Neurizon® Therapeutics Limited (ASX: NUZ & NUZOA; OTCQB: NUZTF) ("Neurizon" or "the Company"), a clinical-stage biotech company dedicated to advancing innovative treatments for neurodegenerative diseases, is pleased to announce the......
|
|
|
|
|
|
|
|
|
26.11.25 - 22:00
|
Should I buy CSL shares in December? (Fool)
|
|
|
After a big fall, is this now the time to jump on CSL shares?
The post Should I buy CSL shares in December? appeared first on The Motley Fool Australia....
|
|
|
|
|
|